The Top Five: USP releases appropriate drug use principles to guide practice

Author：  

Publisher： Joint Commission Resources

ISSN： 1523-8806

Source： Joint Commission Benchmark, Vol.3, Iss.10, 2001-10, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Top Five: Advantages and Disadvantages of Chief Methods of Identifying Drug Safety Problems in Normal Practice

By  

Joint Commission Benchmark, Vol. 2, Iss. 12, 2000-12 ,pp. : 11-11

Joint Commission Resources

Access to resources Recommend Favorite

The Top Five: USP report on medication errors offers foundation for systemic care safety improvements

By  

Joint Commission Benchmark, Vol. 3, Iss. 4, 2001-04 ,pp. : 11-11

Joint Commission Resources

Access to resources Recommend Favorite

The Top Five: Watch for drug-drug interactions with antibiotics for respiratory infections

By  

Joint Commission Benchmark, Vol. 3, Iss. 1, 2001-01 ,pp. : 11-11

Joint Commission Resources

Access to resources Recommend Favorite

Top Five: Evidence-based technology assessment principles and physicians' ranking of innovations

By  

Joint Commission Benchmark, Vol. 4, Iss. 8, 2002-08 ,pp. : 11-11

Joint Commission Resources

Access to resources Recommend Favorite

Top Five: Can you estimate ROI for instituting practice changes?

By  

Joint Commission Benchmark, Vol. 4, Iss. 7, 2002-07 ,pp. : 11-11

Joint Commission Resources

Access to resources Recommend Favorite